Sandoz Pty Ltd. Sandoz Pharmaceutical Import Profile — Australia (DGFT 2022–2026)

Name: Sandoz Pty Ltd. Sandoz Pharmaceutical Import Records from India — 2 Products, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sandoz Pty Ltd. Sandoz — Pharmaceutical Importer Profile (2026) | 2 Products, $1.0M Trade | TransData Nexus

Sandoz Pty Ltd. Sandoz

Pharmaceutical Importer · Australia · Respiratory Focus · $1.0M Total Trade · DGFT Verified

Sandoz Pty Ltd. Sandoz is a pharmaceutical importer based in Australia with a total trade value of $1.0M across 2 products in 1 therapeutic categories. Based on 20 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Sandoz Pty Ltd. Sandoz sources from 1 verified Indian supplier, with Cipla Limited accounting for 100.0% of imports.

Sandoz Pty Ltd. Sandoz — Import Portfolio & Supplier Network

Sandoz Pty Ltd. Sandoz import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Sandoz Pty Ltd. Sandoz?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$2.7M	355	100.0%

Sandoz Pty Ltd. Sandoz sources from 1 verified Indian supplier across 227 distinct formulations. The sourcing is highly concentrated — Cipla Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Sandoz Pty Ltd. Sandoz Import?

Formulation	Value	Ships
Salplusf inhaler 250/25 (fluticasone propionate 250mcg + salmeterol xinafoate 25mcg inhaler)	$450.0K	9
Escitalopram sandoz (as oxalate) 10 MG tablet (escitalopram) . ( inv. qty. 86400 Pack 2 x 14's = 2419200	$86.6K	2
Wagner health childrens ibuprofen 6 months - 12 year (ibuprofen oral suspensionbp 100 MG/ 5ML)	$68.0K	4
Escitalopram sandoz (as oxalate) 20 MG tablet (escitalopram). (inv.qty.87460 Pack 2x14s=2448880 nos	$63.6K	3
Escitalopram sandoz (as oxalate) 20 MG tablet (escitalopram). (inv.qty.87300 Pack 2x14s=2444400 nos	$63.5K	3
Escitalopram sandoz (as oxalate) 20 MG tablet (escitalopram). (inv.qty.86960 Pack 2x14s=2434880 nos)	$50.0K	1
Escitalopram sandoz (as oxalate) 20 MG tablet (escitalopram). (inv.qty.86880 Pack 2x14s=2432640 nos)	$50.0K	1
Escitalopram sandoz (as oxalate) 20 MG tablet (escitalopram). (inv. qty. 86880 Pack 2x14s =2432640 nos)	$50.0K	1
Escitalopram sandoz (as oxalate) 10 MG tablet (escitalopram) . (inv.qty.172800 Pack 2x14s=4838400 nos)	$50.0K	1
Escitalopram sandoz (as oxalate) 10 MG tablet (escitalopram) . (inv.qty.153120 Pack 2 x 14s =4287360 nos )	$50.0K	1
Escitalopram sandoz (as oxalate) 10 MG tablet (escitalopram) . (inv.qty.93930 Pack 2x14s=2630040 nos)	$50.0K	1
Escitalopram sandoz (as oxalate) 10 MG tablet (escitalopram) . (inv.qty.133680 Pack 2 x 14s =3743040 nos )	$50.0K	1
Salplusf dpi 250/50(1x60'sx8400packs=504000nos)(fluticasone propionate 250mcg/salmeterol(as xinfoate) 50mcg powder for	$50.0K	1
Escitalopram sandoz (as oxalate) 10 MG tablet (escitalopram) . ( inv. qty. 120420 Pack 2 x 14's = 3371760	$50.0K	1
Escitalopram sandoz (as oxalate) 10 MG tablet (escitalopram) . ( inv. qty. 119320 Pack 2 x 14's = 3340960	$50.0K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Fluticasone	Respiratory	$500.0K	10	0.2%	14
2	Salmeterol	Respiratory	$500.0K	10	0.7%	5

Sandoz Pty Ltd. Sandoz imports 2 pharmaceutical products across 1 categories into Australia totaling $1.0M.

Sandoz Pty Ltd. Sandoz — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Sandoz Pty Ltd. Sandoz is an Australian private company specializing in the importation and distribution of finished pharmaceutical formulations. Established on October 23, 1996, and registered for Goods and Services Tax (GST) since July 1, 2000, the company operates under the Australian Business Number (ABN) 60 075 449 553 and the Australian Company Number (ACN) 075 449 553. Headquartered in North Sydney, New South Wales, Sandoz Pty Ltd. Sandoz is a subsidiary of Sandoz Group AG, a global leader in generic pharmaceuticals and biosimilars headquartered in Basel, Switzerland.

In Australia, Sandoz Pty Ltd. Sandoz plays a pivotal role in enhancing access to affordable, high-quality medicines. The company imports a diverse range of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, thereby contributing significantly to the pharmaceutical supply chain. By leveraging its global network and expertise, Sandoz Pty Ltd. Sandoz ensures a steady supply of essential medications to meet the needs of healthcare providers and patients across Australia.

2Distribution Network

Sandoz Pty Ltd. Sandoz maintains a robust distribution network within Australia, with its headquarters situated in North Sydney, New South Wales. While specific details regarding warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic positioning in North Sydney suggests proximity to major transportation hubs, facilitating efficient distribution across the country. This central location enables Sandoz Pty Ltd. Sandoz to effectively manage its supply chain and ensure timely delivery of pharmaceutical products to various regions within Australia.

3Industry Role

Sandoz Pty Ltd. Sandoz operates as a pharmaceutical importer and distributor within Australia's supply chain. By importing finished pharmaceutical formulations from international suppliers, the company enhances the availability of essential medications in the Australian market. Its role is crucial in bridging the gap between global pharmaceutical manufacturers and local healthcare providers, ensuring that patients have access to a wide array of therapeutic options.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Sandoz Pty Ltd. Sandoz

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Sandoz Pty Ltd. Sandoz demonstrates a high degree of supplier concentration, sourcing all its imported pharmaceutical formulations from a single supplier, CIPLA LIMITED. This exclusive sourcing strategy indicates a strategic partnership, potentially offering benefits such as favorable pricing, consistent product quality, and reliable supply. However, this dependency also introduces risks; any disruptions in CIPLA LIMITED's production or supply chain could directly impact Sandoz Pty Ltd. Sandoz's ability to meet market demand. The company's shipment data, comprising 20 shipments valued at $1.0 million USD, reflects a stable and ongoing relationship with CIPLA LIMITED, suggesting effective collaboration and mutual trust.

2Supply Chain Resilience

The resilience of Sandoz Pty Ltd. Sandoz's supply chain is closely tied to its exclusive relationship with CIPLA LIMITED. While this partnership may offer advantages in terms of product consistency and supply reliability, it also exposes the company to potential risks associated with single-source dependency. The absence of backup suppliers and limited formulation diversity could pose challenges in the event of supply disruptions. Additionally, the company's reliance on a single supplier may limit its ability to adapt to changing market demands or regulatory requirements. Ensuring the regulatory compliance of CIPLA LIMITED, particularly in adhering to Good Manufacturing Practice (GMP) standards, is essential to maintain the integrity and quality of the imported products.

Importing Pharmaceuticals into Australia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Australia

1Regulatory Authority & Framework

In Australia, the Therapeutic Goods Administration (TGA) serves as the primary regulatory authority overseeing the importation, manufacture, and supply of therapeutic goods, including pharmaceuticals. The TGA operates under the Therapeutic Goods Act 1989, which establishes a national system to ensure the quality, safety, efficacy, and timely availability of therapeutic goods used in Australia. (tga.gov.au) This legislation is complemented by the Therapeutic Goods Regulations 1990, which provide detailed requirements related to the manufacturing, supply, and advertising of therapeutic goods. Additionally, the Poisons Standard, also known as the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP), classifies medicines and poisons into schedules, guiding their regulation and control.

2Import Licensing & GMP

Import licensing in Australia is governed by the Therapeutic Goods Administration (TGA), which requires that all therapeutic goods imported into the country be included in the Australian Register of Therapeutic Goods (ARTG). This inclusion ensures that the products meet the necessary quality, safety, and efficacy standards. Good Manufacturing Practice (GMP) certification is a critical component of the import licensing process. The TGA recognizes GMP certificates from various international standards, including those issued by the European Union (EU GMP), the World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications affirm that manufacturing processes adhere to internationally accepted quality standards. Additionally, wholesale distribution authorization is required for entities involved in the distribution of therapeutic goods, ensuring compliance with regulatory standards and the maintenance of product integrity throughout the supply chain.

Sandoz Pty Ltd. Sandoz — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Sandoz Pty Ltd. Sandoz's product strategy focuses on the importation of pharmaceutical formulations within the respiratory therapeutic category, specifically Fluticasone and Salmeterol. The company's total import value from India amounts to $1.0 million USD, with 20 shipments comprising 227 unique formulations. The exclusive sourcing of these products from CIPLA LIMITED suggests a strategic emphasis on ensuring consistent product quality and supply reliability. The choice to import these specific therapeutic products may be driven by market demand for respiratory treatments in Australia, as well as the availability and quality of these formulations from CIPLA LIMITED.

2Sourcing Profile

Sandoz Pty Ltd. Sandoz's sourcing strategy is characterized by a focus on generic pharmaceutical formulations, particularly within the respiratory therapeutic category. The company's exclusive reliance on CIPLA LIMITED for the importation of these products indicates a strategic partnership aimed at ensuring product consistency and supply chain efficiency. This sourcing approach aligns with Sandoz Pty Ltd. Sandoz's commitment to providing affordable, high-quality medicines to the Australian market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Sandoz Pty Ltd. Sandoz

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

The exclusive sourcing arrangement between Sandoz Pty Ltd. Sandoz and CIPLA LIMITED presents both opportunities and challenges for potential new Indian suppliers. While the existing partnership may limit immediate opportunities for new entrants, there is potential for diversification within the respiratory therapeutic category or expansion into other therapeutic areas. New suppliers could explore offering alternative formulations or products that complement Sandoz Pty Ltd. Sandoz's existing portfolio,

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Sandoz Pty Ltd. Sandoz

What products does Sandoz Pty Ltd. Sandoz import from India?

Sandoz Pty Ltd. Sandoz imports 2 pharmaceutical products across 1 categories. Top imports: Fluticasone ($500.0K), Salmeterol ($500.0K).

Who supplies pharmaceuticals to Sandoz Pty Ltd. Sandoz from India?

Sandoz Pty Ltd. Sandoz sources from 1 verified Indian suppliers. The primary supplier is Cipla Limited (100.0% of imports, $2.7M).

What is Sandoz Pty Ltd. Sandoz's total pharmaceutical import value?

Sandoz Pty Ltd. Sandoz's total pharmaceutical import value from India is $1.0M, based on 20 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Sandoz Pty Ltd. Sandoz focus on?

Sandoz Pty Ltd. Sandoz imports across 1 categories. The largest: Respiratory (100.0%).

Get Full Sandoz Pty Ltd. Sandoz Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.